In the present study, we elucidated the involvement of p-eIF2α, ATF4, and Ihh in the development of NP cell degeneration and found that disrupting the cascade of p-eIF2α/ATF4/Ihh using pharmacological methods is a promising treatment for IDD. This evidence concerns the gene EIF2A and intervertebral disk degenerative disorder.